[Comment] What can be learnt from the world's first national vaccination programme against gonorrhoea

Gonorrhoea, the disease caused by Neisseria gonorrhoeae, is a bacterial sexually transmitted infection (STI) that remains a major public health concern globally, with rising incidence and increasing antimicrobial resistance (AMR) to multiple classes of antibiotics. In 2020, WHO estimated there were more than 82 million cases of gonorrhoea among people aged 15–49 years worldwide, with a global incidence of 19 (1·9%) per 1000 women and 23 (2·3%) per 1000 men. Given the growing international concern, WHO set targets to reduce annual gonorrhoea incidence by 90% by 2030.